Australia markets closed

AVXL Jan 2023 3.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.55000.0000 (0.00%)
As of 11:51AM EDT. Market open.
Full screen
Previous close0.5500
Open0.5500
Bid0.2000
Ask0.8500
Strike3.00
Expiry date2023-01-20
Day's range0.5500 - 0.5500
Contract rangeN/A
Volume10
Open interest502
  • Motley Fool

    Anavex Life Sciences (AVXL) Q3 2022 Earnings Call Transcript

    My name is Clint Tomlinson, and I'll be your host for today's call. The call will also be available for replay on Anavex's website at www.anavex.com. With us today is Dr. Christopher Missling, president and chief executive officer; and Sandra Boenisch, principal financial officer.

  • GlobeNewswire

    Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 Third Quarter Financial Results

    Company to host a webcast today at 4:30 p.m. Eastern Time NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today reported financial results for its fiscal quarter en

  • GlobeNewswire

    Anavex Life Sciences to Announce Fiscal 2022 Third Quarter Financial Results on Tuesday August 9, 2022

    Webcast and Conference Call To be Held Tuesday August 9, 2022, 4:30 pm ETNEW YORK, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that it will issue financia